IN BRIEF: Nuformix hires ex-Zeus Capital joint CEO Metcalfe as chair

Related news

Nuformix PLC - London-based pharmaceutical development company focused on fibrosis and oncology via drug repurposing - Hires Tim Metcalfe to be non-executive chair, starting September 1, Tuesday next week. Metcalfe is a corporate financier who among other City roles was joint CEO of Zeus Capital Ltd. At Nuformix, he replaces Julian Gilbert, who is stepping down for "personal reasons". Gilbert has been on the board since 2020 and chair since 2022.

Current stock price: 0.17 pence, up 1.1% on Tuesday afternoon in London

12-month change: up from 0.070p

Copyright 2026 Alliance News Ltd. All Rights Reserved.

Directors

Ways to help you invest your money

Our investment accounts

Put your money to work with our range of investment accounts. Choose from ISAs, pensions, and more.

Need some investment ideas?

Let us give you a hand choosing investments. From managed funds to favourite picks, we’re here to help.

Read our expert tips and insights

Our investment experts share their knowledge on how to keep your money working hard across the markets.